Picture of Dynasil of America logo

DYSL — Dynasil of America News Story

0.000.00%
us flag iconLast trade - 00:00
TechnologyAdventurousMicro Cap

Brief: Dynasil Announces Submission Of Xcede Technologies' Application For First-In-Human Clinical Trial

Jan 11 (Reuters) - Dynasil Corporation Of America  DYSL.O : 
    * DYNASIL ANNOUNCES SUBMISSION OF XCEDE TECHNOLOGIES' 
APPLICATION 
FOR FIRST-IN-HUMAN CLINICAL TRIAL 
    * DYNASIL CORPORATION OF AMERICA - ANTICIPATES THAT 
PATIENTS WILL 
BE TREATED WITH XCEDE PATCH IN NETHERLANDS IN EARLY 2018 
 
Source text for Eikon:  ID:nPn5LgGnFa  
Further company coverage:  DYSL.O  
 
 ((Bangalore.newsroom@thomsonreuters.com;))

Recent news on Dynasil of America

See all news